On Friday, September 3, 2010, IFEZ signed an investment contract with Verna Biotech Korea to expand its vaccine manufacturing facility. Verna Biotech Korea is a subsidiary of Dutch biopharmaceutical company Krussell, which specializes in vaccine research and development.